SCHEMBL3565253

SCHEMBL3565253

CCOC(=O)/C(=C/Nc1ccc(Cl)cc1)C(=O)c1ccccc1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 4/20 0.58
NPSR1 Q6W5P4 5/20 0.52
MAPT P10636 5/20 0.50
KDM4E B2RXH2 4/20 0.50
RECQL P46063 1/20 0.50
HPGD P15428 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
TDP1 Q9NUW8 3/20 0.49
GAA P10253 4/20 0.49
ALDH1A1 P00352 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MEN1 O00255 1/20 0.47
NPY1R P25929 1/20 0.47
NPY2R P49146 1/20 0.47
KMT2A Q03164 1/20 0.47
MAPK1 P28482 1/20 0.47
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13885851 1.00 DHODH (0.58) DHODHNPSR1MAPTKDM4ERECQL
SCHEMBL3565256 1.00 DHODH (0.58) DHODHNPSR1MAPTKDM4ERECQL
SCHEMBL3566706 0.93 DHODH (0.69) DHODHNPSR1MAPTKDM4ERECQL
SCHEMBL3574899 0.93 DHODH (0.69) DHODHNPSR1MAPTKDM4ERECQL
SCHEMBL3564324 0.92 DHODH (0.56) DHODHNPSR1MAPTKDM4ERECQL
SCHEMBL3564323 0.92 DHODH (0.56) DHODHNPSR1MAPTKDM4ERECQL
SCHEMBL4960325 0.91 DHODH (0.55) DHODHNPSR1MAPTKDM4ERECQL
SCHEMBL3566832 0.91 DHODH (0.55) DHODHNPSR1MAPTKDM4ERECQL
SCHEMBL3568685 0.91 DHODH (0.55) DHODHNPSR1MAPTKDM4ERECQL
SCHEMBL3560174 0.91 DHODH (0.55) DHODHNPSR1MAPTKDM4ERECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825278-B2 Substituted enaminones, their derivatives and uses thereof THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-11-02 US disclosed
US-20080064748-A1 Substituted enaminones, their derivatives and uses thereof OXFORD FINANCE CORPORATION 2008-03-13 US disclosed
EP-1742904-A4 SUBSTITUTED ENAMINONES, THEIR DERIVATIVES AND USES THEREOF UNIV CALIFORNIA (US) 2007-04-18 EP disclosed
EP-1742904-A2 SUBSTITUTED ENAMINONES, THEIR DERIVATIVES AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2007-01-17 EP disclosed
WO-2005108347-A2 SUBSTITUTED ENAMINONES, THEIR DERIVATIVES AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2005-11-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064748-A1 Substituted enaminones, their derivatives and uses thereof GABRB2, GABRB1, GABRB3 DHODH 2623/4885NPSR1 81/4885MAPT 1159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.